Certain probiotic strains such as Akkermansia, Streptococcus thermophilus ST10, Lactobacillus delbrueckii subsp. bulgaricus, and Bifidobacterium show potential benefits for gut health by improving intestinal permeability and gut barrier function, though evidence varies by condition and strain.
What the research shows
High-quality systematic reviews and randomized controlled trials indicate that probiotics can influence gut health by modulating intestinal permeability and gut barrier integrity. Akkermansia shows promise in reducing intestinal permeability associated with obesity, though clinical trial results are inconsistent. Streptococcus thermophilus ST10 combined with tara gum significantly improved intestinal barrier function in healthy subjects. Lactobacillus delbrueckii subsp. bulgaricus-containing probiotics improved mucosal barrier function in diarrhea-predominant IBS patients. Bifidobacterium is commonly found in formulations that improve gut microbiota and reduce permeability, especially in older adults. However, some studies, such as probiotic use to prevent aspirin-induced permeability increases or in chronic kidney disease, show uncertain or no clear benefits. Evidence quality varies, and strain-specific effects are important. More standardized, larger trials are needed.
Best studied probiotic strains
Akkermansia
More standardization in dosage and delivery is needed to confirm effects in humans.
Streptococcus thermophilus ST10
Pilot study; larger trials in subjects with impaired gut permeability are needed.
Lactobacillus delbrueckii subsp. bulgaricus
Part of a multi-strain probiotic formulation; effects specific to small bowel permeability.
Bifidobacterium
Evidence supports benefits but strain-specific data are limited.
Who may benefit
Safety
Probiotic supplementation was generally safe with minimal and non-serious adverse events reported, such as mild gastrointestinal symptoms (flatulence, nausea, diarrhea, abdominal pain). No serious safety concerns were identified in the reviewed studies.
Limitations
Evidence is limited by heterogeneity in probiotic strains, dosages, treatment durations, and study populations. Some clinical trials showed inconsistent or uncertain results. Many studies had small sample sizes or were pilot trials. More high-quality, standardized RCTs are needed to confirm strain-specific effects and long-term benefits. Data on some populations, such as solid organ transplant recipients and chronic kidney disease patients, are insufficient to draw conclusions.
PubMed sources
| Study | Type | Year | PMID |
|---|---|---|---|
| Effect of Probiotic Supplementation on Intestinal Permeability in Overweight and Obesity: A Systematic Review of Randomized Controlled Trials and Animal Studies. Advances in nutrition (Bethesda, Md.) |
Systematic Review | 2024 | 38072119 |
| Synbiotics, prebiotics and probiotics for solid organ transplant recipients. The Cochrane database of systematic reviews |
Systematic Review | 2022 | 36126902 |
| Assessment of the capability of a gelling complex made of tara gum and the exopolysaccharides produced by the microorganism Streptococcus thermophilus ST10 to prospectively restore the gut physiological barrier: a pilot study. Journal of clinical gastroenterology |
Randomized Controlled Trial | 2014 | 25291130 |
| Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Alimentary pharmacology & therapeutics |
Randomized Controlled Trial | 2008 | 18671775 |
| The effect of an acute aspirin challenge on intestinal permeability in healthy adults with and without prophylactic probiotic consumption: a double-blind, placebo-controlled, randomized trial. BMC gastroenterology |
Randomized Controlled Trial | 2024 | 38166769 |
| Synbiotics, prebiotics and probiotics for people with chronic kidney disease. The Cochrane database of systematic reviews |
Systematic Review | 2023 | 37870148 |
| Intestinal Flora Balance Therapy Based on Probiotic Support Improves Cognitive Function and Symptoms in Patients with Alzheimer's Disease: A Systematic Review and Meta-analysis. BioMed research international |
Meta-analysis | 2022 | 36017397 |
| The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT. PloS one |
Randomized Controlled Trial | 2024 | 39485760 |
| Effects of non-pharmacological interventions on gut microbiota and intestinal permeability in older adults: A systematic review: Non-pharmacological interventions on gut microbiota/barrier. Archives of gerontology and geriatrics |
Systematic Review | 2025 | 39305569 |
| A systematic review of microbiome changes and impact of probiotic supplementation in children and adolescents with neuropsychiatric disorders. Progress in neuro-psychopharmacology & biological psychiatry |
Systematic Review | 2021 | 33271210 |
